Introducing recombinant genes into donor hearts may offer a therapeutic intervention that could potentially attenuate the complications of heart transplantation, including rejection, infection and accelerated atherosclerosis. In the cardiovascular system, reduced bioactivity of endothelial nitric oxide is a feature of atherosclerosis and vascular injury. Nitric oxide is an arterial vasodilator that also inhibits proliferation of vascular smooth muscle cells and platelet aggregation. Experiments were designed to determine the distribution of adenoviral-mediated transfer of recombinant endothelial nitric oxide synthase gene (eNOS) and the effect of recombinant gene expression on the function of transplanted hearts. Adenoviral vectors for (a) bovine eNOS (AdeNOS) or (b) b-galactosidase (AdLacZ; control) were infused into two groups (n512, per group) of explanted rat hearts. The transduced hearts were then implanted heterotopically into the abdomen of syngeneic recipient rats. After four days, the hearts were excised and examined for distribution and function of the recombinant genes. Polymerase chain reaction (PCR) verified the presence of the recombinant eNOS gene in eNOS-transduced but not in b-galactosidase-transduced hearts; reverse transcriptase-PCR identified mRNA for eNOS in AdeNOS-transduced hearts. NOS activity (conversion of tritiated L-arginine to citrulline) was greater in homogenates of AdeNOS-compared to AdLacZ-transduced hearts. Positive immunoreactivity for eNOS was present in cardiomyocytes predominantly in eNOS-transduced hearts. Myocardial contractility and coronary blood flow, as determined using a Langendorff preparation, were not different between hearts transduced with AdeNOS or AdLacZ. These results suggest that, up to four days post transplantation, adenoviral-mediated transfer of eNOS into transplanted hearts is possible. However, expression of the recombinant protein did not result in measurable changes in myocardial contractility or coronary perfusion.
Introduction
be multi-factorial and non-immune mechanisms including early ischemia-induced endothelial cell injury, ischemic The one-year survival for heart transplant patients is reperfusion and cytomegalovirus infection may all contribapproximately 80% and more than 50% of patients are ute [6] . alive after five years [1] . However, limitations to long-term Nitric oxide (NO) derived from the vascular endosurvival include the development of accelerated transplant thelium regulates vascular tone and inhibits proliferation of atherosclerosis [2] , rejection [3, 4] , infection and side smooth muscle cells, and adhesion and activation of effects of immunosuppression [5] . The etiology and patholeukocytes and platelets [7] [8] [9] [10] [11] . Therefore, overexpression genesis of accelerated transplant atherosclerosis appears to of nitric oxide may be beneficial in modifying accelerated heart transplant atherosclerosis. Indeed, overexpression of iNOS (by gene transfer) attenuates intimal hyperplasia in 2.2. Animals, operation and gene transfer aortic allografts in rats [11] . However, the role of nitric oxide in a solid organ such as the heart is complex. Under Inbred male Lewis (RT-1 [l]) rats (250 to 300 g) were physiologic conditions, basal release of nitric oxide in the used as donors and recipients. All animals received heart is important in preserving ventricular function [12] .
humane care in compliance with the ''Principles of LabIn contrast, excessive production of NO, secondary to oratory Animal Care'', formulated by the National Society activation of the inducible form of nitric oxide synthase for Medical Research, and the ''Guide for the Care and (iNOS), which occurs in conditions such as allograft Use of Laboratory Animals'', prepared by the Institute of rejection [13] and endotoxemia, reduces myocardial conLaboratory Animal Resources and published by the Natractility [14] [15] [16] .
tional Institutes of Health (NIH Publication No. 86-23, Recent advances in molecular biology have resulted in revised 1985). the development of vector systems for transferring recomHeterotopic abdominal heart transplantation using stanbinant genes into cells and organs [17] . Thus, gene transfer dard microsurgical techniques was performed [19] . After may be a useful tool for studying the pathogenesis of these anesthesia with pentobarbital (30 mg / kg, intraperitonealprocesses and may have potential therapeutic implications ly), the donor rat was intubated and ventilated (Harvard for modifying accelerated transplant atherosclerosis.
Rodent Ventilator). A median sternotomy was performed to Therefore, experiments were designed to determine the expose the heart. The rat was heparinized with 200 U of distribution and functional consequences of overexpressing aqueous heparin injected into the inferior vena cava. The the eNOS gene in the transplanted heart.
innominate artery was cannulated with a 24-gauge cannula and the venae cavae and pulmonary veins were ligated en bloc with 4 / 0 silk. The pulmonary artery was divided and the ascending aorta tied distal to the cannula. The donor 2. Methods heart was arrested with an infusion of cold cardioplegic solution (Plegisol, Abbott Laboratory) into the aortic root 2.1. Construction, propagation and purification of via the indwelling cannula. The donor heart was then adenoviral vector excised and transferred to a cardioplegic solution at 48C. Either the eNOS or the LacZ (control) gene at a con- 9 A recombinant adenovirus containing the cDNA encodcentration of 1310 pfu / ml (total volume, 0.350 ml) was ing eNOS was generated as previously described [18] . infused over 5 s into the coronary arteries via the aortic Briefly, bovine eNOS cDNA was cloned into the shuttle root. The pulmonary artery was clamped during viral plasmid pACCMVpLpA. The resulting plasmid was linearinfusion and the viral solution was not flushed out at the ized with NruI and cotransfected with d1309 into 293 cells end of 60 min cold storage prior to performing heart by calcium phosphate / DNA coprecipitation. d1309 is a transplantation. All donor hearts were heterotopically biologically selected, restriction enzyme-site-loss variant transplanted into the recipients by end-to-side anastomoses of wild type adenovirus type 5, which retains only a single of the aorta and the pulmonary artery to the abdominal Xba1 site at nucleotide 1339. 293 cells are human emaorta and inferior vena cava, respectively, using 10 / 0 bryonic kidney carcinoma cells that have been transformed monofilament sutures. All rats received Torbugesic as with the left end of human adenovirus type 5 DNA.
analgesia post-operatively. Viability of the grafts was Recombinant adenoviral vectors were generated by verified daily by palpation of the beating transplanted homologous recombination. Viral plaques were picked and heart. propagated in 293 cells. Viral DNA was enriched by Hirt extraction and screened by restriction mapping and poly-2.3. Tissue analysis merase chain reaction (PCR) for the presence of eNOS cDNA. Positive plaques underwent two further rounds of Transplanted hearts (n512 per group) were harvested plaque purification in 293 cells. Stocks were prepared from four days after surgery. For PCR, RT-PCR, immunopositive plaques and these were used to generate high titer histochemical staining and NOS activity assay, hearts (n5 preparations. Viral preparations were prepared by infecting 6 per group, except PCR for control, n52) were flushed a confluent monolayer of 293 cells in T175 flasks with with phosphate-buffered saline (PBS) solution and then cut viral stock at a multiplicity of infection (MOI) of 1-10. into apical, mid-ventricular and basal sections. For assessVirus was purified by double cesium gradient ultracentrifument of ventricular function, transplanted hearts (n56 per gation and was dialyzed against 10 mmol / l Tris, 1.0 group) were removed and prepared for Langendorff perfummol / l MgC1 , 1.0 mmol / l Hepes and 10% glycerol for 4 sion. The presence of recombinant eNOS DNA from the transduced hearts was analyzed by PCR. Genomic DNA fixed for 10 min in cold acetone (48C), fan-dried for 10 was prepared from apical and basal segments of eNOSmin and further fixed in 1% paraformaldehyde / EDTA for (n56) and LacZ-transduced hearts, (n52 as control) by 3 min. Endogenous peroxidase activity was blocked with standard proteinase K digestion in phenol and chloroform 0.1% sodium azide / 0.3% H O for 10 min. Incubating 2 2 extraction conditions. Primer sequences utilized for the sections with 5% goat serum / PBS-Tween 20 blocked experiments were as follows: upper 59 AGG CGT CGG non-specific protein binding sites. Then, 5 mg / ml of anti-TGG GAG GTC TAT, lower 59 GCG CAC AGA GTG eNOS monoclonal antibody (N30020) (Transduction Lab-TCG TAG GTG ATG. The upper primer was complemenoratories, Lexington, KY, USA) was added and the samtary to the CMV promoter. A 1-mg amount of DNA was ples were incubated for 60 min at room temperature. After amplified using 35 PCR cycles (948C for 30 s, 638C for 30 rinsing, biotinylated rabbit anti-mouse F(ab9)2 (1:300) was s and 728C for 30 s). The PCR product amplified was 356 added for 20 min. After further incubation for 20 min with base pairs in length.
peroxidase conjugated-streptavidin (1:300), the slides were incubated for 30 s in 0.1 M sodium acetate buffer, pH 5.2.
Reverse transcriptase PCR (RT-PCR)
Then the slides were placed in AEC (3-amino-9-ethylcarbazole) substrate solution and incubated for 15 min at Expression of recombinant eNOS mRNA was detected room temperature, counterstained in mercury-free hematoby RT-PCR. Total RNA was prepared from apical and xylin for 1 min and further rinsed for 3 min in cold basal segments of transplanted hearts using RNA STAT-60 running tap water before being mounted. Myocardial cells isolation reagent (Tel-Test ''B'', Friendswood, TX, USA).
with immunoreactivity were then counted from all five Reverse transcription was performed using a SuperScript sections of both control (LacZ) and experimental (eNOS) preamplification system for first strand cDNA synthase kit groups and a mean was calculated for each heart. (Life Technologies, Gaithersburg, MD, USA). Total RNA was transcribed into cDNA using oligo(dT) priming meth-2.8. Assessment of gene transfer efficiency ods according to the manufacturer's protocol. RT-generated cDNA encoding for the eNOS gene was amplified
The area of each section was obtained using an Axusing 35 PCR cycles (948C for 45 s, 608C for 45 s and iophot photomicroscope (Carl Zeiss, Oberkochen, Ger-728C for 60 s). Sequences utilized for the experiments many) equipped with a 2.53 objective lens. Brightfields were as follows: upper 59 TCAACCAGTACTACAGCTCC, images were digitized to 256 gray levels on an IBAS lower 59 GTGGTTGCAGATGTAGGTGA. These primers image analysis system (Kontron Elektronik, Munich, Gerwere derived from bovine eNOS sequence and they do not many) using a black and white Newvicon video camera generate PCR product with endogenous rat eNOS. Primers (Hamamatsu, Tokyo, Japan). Each image was analyzed designed to detect expression of glyceraldehyde 3-phosusing a macro computer program written with software phate dehydrogenase (G3PDH; Amplimer set, Clontech supplied by the IBAS system. The number of cells per Laboratories, Palo Alto, CA, USA) were used to test the section was estimated by dividing the area by the mean efficiency of cDNA synthesis. The PCR product for eNOS dimension of a cardiomyocyte [20] . Efficiency was calcumigrates to 250 base pairs and the G3PDH at 450 base lated as the number of positive cells divided by the total pairs. number of cells. As endothelial cells and interstitial cells are present, this results in an underestimate. 2.6. X-gal staining 2.9. NOS activity Sections (5 mm-thick) of LacZ-transduced hearts were fixed in 1.25% glutaraldehyde for 15 min at 48C and then NOS activity of LacZ-(as control) and eNOS-transrinsed twice with PBS (Gibco BRL, Gaithersburg, MD, duced hearts was determined by measuring the conversion 3 3 USA). The sections were stained in a solution of 500
ly described by Myatt et al. [21] and modified by Miller (X-Gal) (Boehringer Mannheim, Indianapolis, IN, USA) and Barber [22] . In brief, tissue homogenates from midfor 4 h at 378C. The sections were rinsed in PBS and ventricular sections of transplanted hearts were prepared counterstained with eosin. Blue-stained cells indicated the and eluted through 10-DG desalting columns (Bio-Rad presence of b-galactosidase expression.
Laboratories, Hercules, CA, USA). To quantitate NOS activity, duplicate reactions were carried out in the pres-2.7. Immunohistochemical staining ence of calcium (total activity), in the absence of calcium plus EGTA (calcium-independent activity) and in the G Midventricular cross sections of the transplanted hearts absence of calcium plus EGTA in the presence of Nwere embedded in OCT medium (Miles, Elkhart, IN, monomethyl-L-arginine (L-NMMA; non-specific activity). USA) and frozen in a liquid nitrogen-cooled isopentane Reaction mixtures of homogenate (150 ml) and cofactor bath. Sections (5 mm thick) were cut at 25 mm intervals, (150 ml) were incubated at 278C for 1 h. Separation of [ H]-L-citrulline produced per mg of protein per hour. extracted from eNOS-and LacZ-transduced hearts. Bands Calcium-dependent activity equaled total activity minus at 356 base pairs corresponding to positive control for calcium-independent activity after correcting for non-spebovine eNOS were present in all lanes for eNOS-transcific activity.
duced hearts (n56). In contrast, no bands were seen in the controls (LacZ-transduced hearts, n52; Fig. 1 To confirm the presence of recombinant protein, imfunction was expressed as left ventricular developed munohistochemical staining was performed. As the antipressure (LVDP5left ventricular systolic pressure minus body to eNOS was not specific for recombinant eNOS, left ventricular diastolic pressure). Left ventricular function endothelial cells in both the eNOS and the LacZ groups curves were constructed by progressively increasing the were immunoreactive for eNOS. (Fig. 4 a, b) In the volume of the balloon to achieve end-diastolic pressures (LVEDP) of 0, 4, 8, 12, 16 and 20 mmHg. Following the assessment of cardiac function, the LVDP was maintained at the optimal level and the heart was allowed to stabilize for 5 min. Coronary flow was measured at 1, 2, 3, 4, 5, 10, 15, 20 and 25 min after beginning a continuous infusion of 24 L-NMMA (10 M).
Statistical analysis
All data are expressed as mean6SEM; n represents the number of animals; the number of cells staining positively for eNOS and NOS activity as picomol / mg protein / h were compared using a two-tailed Student's t-test unpaired for unpaired data. For analysis of left ventricular function, (Fig. 5) . Calcium-dependent activity of NOS was 38.464.7 pmol / mg protein / h in the LacZ-transduced group vs. 5365 pmol / mg protein / h in the eNOS-transduced group (P50.05). Calcium-independent activity of NOS was 3.360.5 pmol / mg protein / h Mean coronary flow after the initial period of stabilizasignals for eNOS mRNA. These primers were derived from the bovine tion was 11.760.5 ml / min in the LacZ group and eNOS sequence and they do not generate PCR product with endogenous 10.960.7 ml / min in the eNOS group. There were no eNOS.
significant differences in cardiac function as measured by LVDP between the two groups (n56 per group, Fig. 6 ).
L-NMMA affected coronary flow comparably in each LacZ-transduced hearts, the mean number of immunogroup (Fig. 7) . During the initial period of L-NMMA reactive myocytes per section was 261 (mean6SE, Fig. infusion, coronary flow in all hearts increased transiently, 4a). In the eNOS-transduced hearts, the mean number of but then decreased by 25% of baseline flow within 2 min. immunoreactive cardiomyocytes per section was 2546102 (mean6SE, Fig. 4b ). (P,0.05). The greatest concentration of transduced cells was near zones of organizing ischemia.
4. Discussion Zones of ischemia were also present in the LacZ-transduced hearts but myocytes surrounding such foci showed
The aim of the present study was to demonstrate the no overexpression of eNOS (Fig. 4a) feasibility and functional consequences of overexpressing eNOS in the transplanted heart using adenoviral-mediated gene transfer. Successful gene transfer and transgene 3.5. Assessment of efficiency of gene transfer expression in the transplanted heart was confirmed by PCR, RT-PCR, immunohistochemical staining and meaThe mean area of the sections (n530, six animals) was 2 surement of functional NOS activity. Recombinant gene 37.38 mm . The mean dimensions of a cardiomyocyte are expression, however, did not affect ventricular function or 80315 mm. This results in an efficiency of 0.81%. coronary flow, as assessed using a Langendorff preparation following heterotopic heart transplantation (non-loaded left ventricular chamber). This study demonstrated the feasibility of using adenoviral vectors for gene transfer of a biologically relevant molecule to the transplanted heart. Adenoviralmediated gene transfer was used because it has been shown to efficiently transduce non-replicative cells. Furthermore, in the transplantation setting, some of the limitations of this technology, including the transient nature of transgene expression [23] and the difficulty of achieving prolonged luminal contact of vector in coronary vessels, may be partially overcome. The period from harvest to implantation of the donor heart may allow for a prolonged period of viral vector exposure of up to 4 h. In addition, the necessary and routine use of immunosuppression may prolong the duration of transgene expression aortic root. We have previously demonstrated, using bwas also detected in small numbers of ventricular galactosidase as a marker, that this method of administramyocytes of AdLacZ-transduced hearts. This observation tion results predominantly in expression of the transgene in is consistent with previous studies [28] [29] [30] showing the cardiomyocytes [24] . We estimated that the transgene was presence of eNOS in cardiomyocytes. expressed in approximately 1 in 100 myocytes, which is
The potential effect of nitric oxide on myocardial consistent with a previous report of gene transfer to the function has been the subject of many studies with transplanted heart [26] . Transgene expression appeared conflicting conclusions. The excessive and prolonged somewhat more accentuated around subepicardial zones of production of NO by iNOS in transplantation rejection and organizing ischemia. This may be explained by the fact sepsis may be responsible for the negative inotropic effect that the subepicardial area of the heart rewarms sooner on cardiac muscles [13, 15, 16] . In contrast, other studies on during the transplantation procedure, as it is more exposed isolated heart preparations showed that increasing NO to the heat from the operating light and also the ambient using NO donors resulted in enhanced cardiac contractility temperature of the room. Thus, as the entry of adenovirus [31] and supplementation of NO during the period of into cells is a temperature-dependent process [27] , enhanced gene transfer may be seen in areas that have higher temperature than surrounding regions. Interestingly, eNOS assessed by Langendorff preparation. Left ventricular function was The AdeNOS-transduced hearts showed greater levels of total and expressed as LVDP mmHg (mean6SEM). No significant difference in calcium-dependent NOS activity compared to AdLacZ-transduced hearts, LVDP was detected between AdLacZ-and AdeNOS-transduced hearts P50.05. Calcium-independent NOS activity was similar in both groups.
(n56 per group, P.0.05).
transfer, leading to a controlled release of NO at the target area, may modify this process [9, 35] without compromising cardiac function and avoiding systemic effects. In our model, however, transgene expression was mainly detected in cardiomyocytes. In contrast, rare endothelial cells expressed the transgene. The reason for this pattern of transgene expression is unclear. Thus, it remains to be seen if this pattern of overexpression of eNOS will influence intimal processes such as smooth muscle cell hyperplasia. However, NO is diffusible and we have previously shown that adventitial expression of eNOS in the rabbit carotid artery or the canine basilar artery can effect vascular Fig. 7 . Four days after gene transfer and transplantation, AdeNOS-and AdLacZ-transduced hearts were explanted and coronary flow was asreactivity [36, 37] . This suggests that eNOS overexpression In summary, delivery of genes to the transplanted heart Infusion of L-NMMA caused comparable changes in coronary blood flow in AdLacZ-and AdeNOS-transduced hearts.
via the aortic root targets cardiomyocytes. In this study, we demonstrate successful gene transfer of eNOS to the transplanted heart using PCR, RT-PCR, immunohistoischemia-reperfusion has also been shown to have benefichemistry and measurement of NOS activity in AdeNOScial effects [32, 33] . Furthermore, cardiac preservation in transduced hearts and controls. Approximately 1 in 100 the heterotopic heart transplant model was enhanced by myocytes expressed the transgene. eNOS overexpression supplementation of the nitric oxide pathway [34] . In a in cardiomyocytes in this model did not result in alteration recent study, the importance of basal NO production in of myocardial contractility or coronary blood flow. In the preserving myocardial systolic function and coronary future, methods that enhance gene transfer efficiency may vascular tone was demonstrated [12] . Therefore, the role of prove useful for modifying these variables in the donor eNOS in cardiomyocytes is unclear. To address this issue, organ. Whether or not transduction of cardiomyocytes will we studied the effect of overexpression of eNOS on the modify vascular consequences of transplantation remains contractility and coronary flow of the transplanted heart in to be determined. a model in which eNOS overexpression was predominantly in cardiomyocytes. Using the Langendorff model, in spite of documented eNOS overexpression, this study did not
